Please login to the form below
CEO
This page shows the latest CEO news and features for those working in and with pharma, biotech and healthcare.
Boehringer’s Corsico to be new GSK drug dev leader
The UK-headquartered firm has underperformed on R&D and commercialisation in recent years, and CEO Emma Walmsley is determined to create a more focused and productive pharma division.
Latest news
-
Biotech leaders jump into US free speech debate
Alnylam chief executive John Maraganore, Decibel Therapeutics’CEO Steve Holtzman, Acorda CEO Ron Cohen and Jeremy Levin of Ovid Therapeutics are the main signatories to the letter published In Nature, but
-
Sanofi swaps execs with Bayer, looks to staunch diabetes, cardio decline
Dieter Weinand joins Sanofi from 1 November and will report directly to CEO Olivier Brandicourt, and will be based in the Bridgewater, New Jersey in the US.
-
FDA awards another non-opioid pain drug breakthrough status
Frank Bellizzi, CEO of Concentric Analgesics said the BTD confirmed the strong early data for the treatment, which is designed to treat pain and eliminate the need for opioids in the
-
Takeda rebels take aim at Shire acquisition
CEO Christophe Weber – the first non-Japanese executive to hold the reins at Japan’s biggest drugmaker – is adamant that absorbing Shire will help Takeda grow outside Japan and enrich the
-
Health secretary’s ‘rip off’ remarks anger UK pharma
Vertex has called NHS England’s refusal to accept its latest offer as ‘outrageous’with the company’s CEO Jeff Leiden writing to Prime Minister Theresa May over the summer to
More from news
Approximately 3 fully matching, plus 1,159 partially matching documents found.
Latest Intelligence
-
Trust me, I’m from pharma
compliance against regulation in the core areas where pharma has tripped up in the past, says Dennis O’Brien, CEO, Lucid Group.
-
Bluebird Bio: on the cusp of a gene therapy revolution
CEO Nick Leschly (pictured below) talks to PME’s Andrew McConaghie about the company’s ambitious plans, and why it’s filing first in Europe. ... Pharmaceutical Market Europe spoke to Bluebird’s CEO Nick Leschly shortly after it unveiled data at
-
Communication is the key to unlocking the potential of immuno-oncology
patients. David Hunt, CEO of Havas Lynx Group, writes why Big Communication in the age of IO will be crucial to realising the potential of this groundbreaking new treatment modality. ... David Hunt, CEO, Havas Lynx Group. This new treatment –
-
The rise of vertical integration in the US payer landscape
During a CNBC interview Cigna CEO David Cordani emphasised this acquisition would “[improve] affordability and personalization for customers and clients, and [drive] more choice, great alignment with healthcare professionals, and more
-
Diversity and inclusion in the pharma industry
Jodie Morrison, CEO of Tokai Pharmaceuticals and Robert K Coughlin, President and CEO of MassBio, in a recent article on GPG in STAT, summed up why it is important: ‘The global ... If, as GlaxoSmithKline CEO Emma Walmsley said, talking about diversity
More from intelligence
Approximately 0 fully matching, plus 149 partially matching documents found.
Latest appointments
-
imc, ROAD, Executive Insight and Life Healthcare adds to teams
imc group's President and CEO Shairose Ebrahim said the new division will bring the group’s human-centric approach to a broader range of clients looking for compliance, medical signatory,
-
Ipsen hires general manager, Laura Hamill joins Gilead and Orchard expands leadership team
Hamill's hiring helps bring in fresh blood to the company, which has seen many of its long-standing senior executives, including CEO John Milligan, announce their departure in the last ... John Milligan, president and CEO of Gilead, said: “Over the
-
BMS appoints CCO, Stephen Davies joins Eisai and more
Peter Llewellyn-Davies, President and CEO of Apeiron, said: "Gaweco’s timely appointment will help chart the continued innovation of our R&D pipeline of cutting-edge cancer immunotherapies, bring forward
-
Healthcare Comms appointments
Shairose Ebrahim, group president and CEO, IMC, said: “[Andrew’s] strategic behavioural science know-how coupled with his expertise in health- and medicines-related behaviour will provide our clients with a
-
Medicen Paris Region appoints new CEO
Medicen Paris Region appoints new CEO. Stéphana Roques joins the European health cluster.
More from appointments
Approximately 0 fully matching, plus 654 partially matching documents found.
Latest from PMHub
-
Making a Difference - The Future of Pharma
Making a Difference - The Future of Pharma. In the July/August edition of PME, Dennis O’ Brien, Lucid CEO and co-founder, discusses the public perception of the pharma industry today,
-
Global Influencers in Diabetes Insights report
but a multitude of therapy areas, we’ re compelled to ensure our research projects follow this trend where appropriate” says George Ashford, CEO at CMR.
-
Powerful digital content management for the life sciences
Anthill Activator will transform how people can work with their content," said Katrine Bach, CEO, Anthill Agency. "
-
Hanson Zandi Press Release
Mark Cornwell, CEO of HPS said, “ We believe thatour multi-channel capability and industry-specific insight enable us to be a true strategic partner.
-
Fishawack Group acquires Healthcircle to strengthen creative offering
David Ingram, Strategic Director; Bottom row: Mike Taylor, Healthcircle Managing Director, Oliver Dennis, Fishawack CEO .
More from PMHub
Approximately 0 fully matching, plus 178 partially matching documents found.
Featured jobs
-
Account Manager
-
Negotiable
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
-
Systematic Review Lead- London
-
Negotiable
-
Sudler London - Account Director
-
Competitive
-
Healthcare PR Senior Account Manager
-
Salary TBC
- Senior Medical Writer, Principal Medical Writer, Scientific Dire...
-
£40000 - £75000 Bonus Benefits
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Senior Medical Writer
-
Salary is DOE
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
- Account Manager, Healthcare Advertising
-
£30 - 38, 000 (or -)
- Account Director or Senior Account Director
-
Salary TBC
- Sudler London - Senior Medical Writer
-
Competitive
- Senior Writer, Healthcare Advertising, London
-
Excellent package
-
Senior Training Manager - Surrey
-
Competitive Salary &Bonus
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
Subscribe to our email news alerts
- IPA’s new training course, Silver Buck launched and ARK moves office
- NHS wins legal fight with pharma over off-label Avastin
- Gilead and ViiV among winners at PM Society Digital Awards
- The critical role of science in healthcare communications
- UK pharma to work with innovation network on NHS uptake
- Bayer roll-out of haemophilia drug Jivi gathers pace
PMHub
Ashfield
Transforming healthcare outsourcing. From small beginnings in 1997, Ashfield has grown rapidly into an international healthcare services organisation. By anticipating...
Latest intelligence
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
- What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
- GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....
Quick links
Infographics
